ATE162074T1 - Oculare hypotensive mittel - Google Patents

Oculare hypotensive mittel

Info

Publication number
ATE162074T1
ATE162074T1 AT93202691T AT93202691T ATE162074T1 AT E162074 T1 ATE162074 T1 AT E162074T1 AT 93202691 T AT93202691 T AT 93202691T AT 93202691 T AT93202691 T AT 93202691T AT E162074 T1 ATE162074 T1 AT E162074T1
Authority
AT
Austria
Prior art keywords
ocular hypotensive
ocular
hypotensive agents
composition
dacryops
Prior art date
Application number
AT93202691T
Other languages
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Tomio Oda
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP24872188A external-priority patent/JPH0739344B2/ja
Priority claimed from JP24872088A external-priority patent/JPH0739343B2/ja
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE162074T1 publication Critical patent/ATE162074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Endoscopes (AREA)
AT93202691T 1988-10-01 1989-09-29 Oculare hypotensive mittel ATE162074T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24872188A JPH0739344B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤
JP24872088A JPH0739343B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤

Publications (1)

Publication Number Publication Date
ATE162074T1 true ATE162074T1 (de) 1998-01-15

Family

ID=26538919

Family Applications (2)

Application Number Title Priority Date Filing Date
AT89310016T ATE111736T1 (de) 1988-10-01 1989-09-29 Okulare hypotensive mittel.
AT93202691T ATE162074T1 (de) 1988-10-01 1989-09-29 Oculare hypotensive mittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT89310016T ATE111736T1 (de) 1988-10-01 1989-09-29 Okulare hypotensive mittel.

Country Status (3)

Country Link
EP (2) EP0580268B1 (de)
AT (2) ATE111736T1 (de)
DE (2) DE68918391T2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1300150A3 (de) * 1988-09-06 2003-05-14 Pharmacia Aktiebolag Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
TW224942B (de) * 1990-04-04 1994-06-11 Adka Ueno Kk
ATE114470T1 (de) * 1990-05-22 1994-12-15 R Tech Ueno Ltd Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.
ES2069823T3 (es) * 1990-05-22 1995-05-16 R Tech Ueno Ltd Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
US5166175A (en) * 1990-05-22 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination
TW210287B (de) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
EP0664707B1 (de) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
AU5258698A (en) * 1996-11-12 1998-06-03 Alcon Laboratories, Inc. 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
SE9900672D0 (sv) 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
CA2454422A1 (en) * 2001-07-31 2003-02-13 Ryuji Ueno Treatment of ocular hypertension and glaucoma
KR20040029012A (ko) * 2001-08-23 2004-04-03 수캄포 아게 안내압항진 및 녹내장 치료용 방법 및 조성물
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356581A (en) * 1970-10-09 1974-06-12 Ici Ltd Cyclopentane derivatives
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
JPH0762626B2 (ja) * 1987-06-23 1995-07-05 株式会社大洋バルブ製作所 流量検出器
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化

Also Published As

Publication number Publication date
EP0580268A2 (de) 1994-01-26
ATE111736T1 (de) 1994-10-15
DE68928551T2 (de) 1998-04-23
DE68918391T2 (de) 1995-01-19
EP0580268B1 (de) 1998-01-14
DE68918391D1 (de) 1994-10-27
EP0366279A3 (de) 1991-12-27
EP0366279B1 (de) 1994-09-21
DE68928551D1 (de) 1998-02-19
EP0580268A3 (de) 1994-02-23
EP0366279A2 (de) 1990-05-02

Similar Documents

Publication Publication Date Title
ATE162074T1 (de) Oculare hypotensive mittel
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
ATE251458T1 (de) Nervenschutzende für auge von säugern unter anwendung von kaliumkanalblockern
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
NO913136D0 (no) Preparat for oeyedraaper.
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
EP1110554A4 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
EP0363469A4 (en) Lacrimal secretion stimulant (lss)
BR0210238A (pt) Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
DE69430521D1 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension
FI962976L (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
DE69825981D1 (de) 4,5-dihydroxy-2-cyclopenten-1-on für die Behandlung von Diabetes Mellitus
EP1121932A4 (de) Heilmittel für augenerkrankungen
NO973122D0 (no) Middel for å minske okular spenning
EP1364953A4 (de) Triazolochinazolin- und pyrazolotriazolopyrimidinderivate, medizinische zusammensetzungen, mittel mit adenosin-a3-rezeptoraffinität, mittel, die den augeninnendruck senken, zubereitungen zur prävention und behandlung von glaukom und verfahren zur senkung des augeninnendrucks"
CA2240271A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
EP1300149A3 (de) Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties